TREATMENT OF RECCURRENT GEMOPHTHALMS AT PATIENTS WITH DIABETIC RETINOPATHY: NEW APPROACH
In 19 patients (14 women, 5 men) with diabetes mellitus type 1 (11 persons) and diabetes mellitus type 2 (8 persons) with bilateral proliferative diabetic retinopathy complicated by recurrent hemophthalm (38 eyes) at the age of 22-67 years conservative treatment was carried out in combination with haemostatics and angioprotectors: tranexam (exacyl) — 1000 mg/day, dicynone — 500 mg/day, endotelon — 300 mg/day in continuous mode and angiovit — 1 tablet in day (courses for 1 month, 3 times a year). This therapy contributed to blood resorption in vitreous body after 2-4 months and prevented re-bleeding that allowed to carry out adequate peripheral laser coagulation, to achieve regression of newly-formed vessels and to enhance the maximum corrected visual acuity (MCVA) from 0,1±0,02 to 0,39±0,04. Within 3 years of observation MCVA increased in 90% of cases and changes in eye fundus stabilized in 97% of cases.